Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Buy
17,842
+7,757
+77% +$203K 0.15% 147
2026
Q1
$273K Buy
10,085
+713
+8% +$19K 0.11% 210
2025
Q4
$259K Sell
9,372
-1,426
-13% -$36K 0.11% 209
2025
Q3
$275K Buy
+10,798
New +$267K 0.13% 181

Other funds holding PFE

QTR Family Wealth's PFE Position: Q2 2026 in Review

QTR Family Wealth increased its Pfizer (PFE) stake by 77% in Q2 2026, buying an estimated $203K and bringing the position to 17,842 shares worth $430K. The position accounts for 0.15% of the portfolio, ranked #147.

QTR Family Wealth first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. 1,596 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • QTR Family Wealth held 17,842 shares of Pfizer worth $430K as of Q2 2026.
  • QTR Family Wealth bought 7,757 Pfizer shares in Q2 2026, an estimated $203K.
  • Pfizer made up 0.15% of QTR Family Wealth's portfolio in Q2 2026, its #147 holding.
  • QTR Family Wealth first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • 1,596 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on QTR Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.